Memory and mood during the night and in the morning after repeated evening doses of MDMA
KPC Kuypers, M. Wingen, Jg Ramaekers
Journal of Psychopharmacology February 28, 2008 DOI: 10.1177/02698811080220081401 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Double-blind, placebo-controlled, two-way crossover study Peer reviewed |
|---|---|
| Sample size | 14 |
| Population | Healthy subjects |
| Intervention | MDMA |
| Dose | 75 and 50 mg divided over the evening |
| Duration | Overnight, with memory tests at baseline, 6:30 pm, 9:30 pm, 1:30 am, and 7 am (1.5, 1.5, 5.5, and 11 hours relative to first dose) |
| Topics | MDMA |
| Keywords | Evening Placebo Morning Mood Memory impairment Sleep deprivation Audiology Stimulant |
| Citations | 28 |
| Key points | Evening doses of MDMA add to the memory impairment caused by sleep deprivation, selectively impairing verbal and spatial memory performance. |
Abstract
Previously it has been shown that MDMA causes memory impairment during daytime testing. However, MDMA is usually taken in the evening or during the night. In addition, it is known that sleep deprivation also causes memory impairment. The present study aimed to assess whether evening doses of MDMA added to, or interacted with the memory impairment due to sleep deprivation. Fourteen healthy subjects participated in a double-blind, placebo-controlled, two-way cross-over study. Treatments consisted of MDMA 75 and 50 mg divided over the evening or double placebo. Memory tests and subjective measures of mood were conducted at baseline and three times post dosing that is at 6.30 pm, 9.30 pm, 1.30 am and 7 am, respectively —1.5, 1.5, 5.5 and 11 h relative to drug intake (first dose). Memory performance detoriated progessively over time as a function of sleep loss, independent of treatment. MDMA added to this impairment as indicated by a significant main effect of MDMA on verbal and spatial memory performance. Mood ratings and response speed revealed an MDMA by Time interaction. After administration of MDMA response speed improved and feelings of vigor, friendliness, elation, anxiety, confusion, arousal and positive mood increased in magnitude during the night, while all these parameters returned to placebo-like levels on the final morning session. It is concluded that evening doses of MDMA selectively impair memory performance, and that this impairment is additional to the effect of sleep deprivation on memory performance.
Comparable studies
Other randomized controlled trials on MDMA, most cited first.
Citations in the library
Cited by 17
- Efficacy and safety of psychedelics for the treatment of mental disorders: A systematic review and meta-analysis. Psychiatry Research May 1, 2024
- 3,4-methylenedioxymethamphetamine (MDMA): current perspectives Substance Abuse and Rehabilitation November 1, 2013
- Dose-related effects of MDMA on psychomotor function and mood before, during, and after a night of sleep loss Psychopharmacology January 18, 2010
- Can MDMA Play a Role in the Treatment of Substance Abuse? Current Drug Abuse Reviews June 1, 2013
- MDMA interactions with pharmaceuticals and drugs of abuse Expert Opinion on Drug Metabolism & Toxicology March 31, 2020
and 12 more in the library
Cites 13
- Human Pharmacology of MDMA Therapeutic Drug Monitoring March 19, 2004
- Human psychopharmacology of Ecstasy (MDMA): a review of 15 years of empirical research Human Psychopharmacology: Clinical and Experimental December 1, 2001
- Human Pharmacology of 3,4-Methylenedioxymeth-amphetamine ("Ecstasy"): Psychomotor Performance and Subjective Effects Journal of Clinical Psychopharmacology August 1, 2000
- The confounding problem of polydrug use in recreational ecstasy/MDMA users: a brief overview Journal of Psychopharmacology March 1, 2006
- Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users: the longitudinal perspective Journal of Psychopharmacology March 1, 2006
and 8 more in the library